Novartis AG (NVS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 26.61B | 30.46B | 28.2B | 25.94B | 25.11B | 29.7B | 31.26B | 25.69B | 26.45B | 30.48B | 45.66B | 33.49B |
| Cash & Short-Term Investments | 6.98B | 11.59B | 9.75B | 7B | 7.2B | 13.35B | 14.02B | 8.44B | 9.69B | 14.43B | 12.7B | 11.17B |
| Cash Only | 6.88B | 11.44B | 9.56B | 6.66B | 7.07B | 11.46B | 13.61B | 7.9B | 9.47B | 13.39B | 12.4B | 10.88B |
| Short-Term Investments | 100M | 155M | 197M | 344M | 130M | 1.89B | 411M | 532M | 225M | 1.03B | 290M | 289M |
| Accounts Receivable | 9.6B | 10.93B | 8.98B | 9.18B | 8.72B | 8.21B | 8.15B | 8.48B | 8.25B | 8.12B | 7.1B | 9.54B |
| Days Sales Outstanding | 68.33 | 69.46 | 57.55 | 54.9 | 55.96 | 55.51 | 58.08 | 59.14 | 61.47 | 59.46 | 63.31 | 72.54 |
| Inventory | 6.29B | 6.27B | 6.42B | 6.31B | 5.83B | 5.72B | 5.94B | 5.75B | 5.74B | 5.91B | 5.61B | 8.23B |
| Days Inventory Outstanding | 163.33 | 166.61 | 163.64 | 166.22 | 161.09 | 161.39 | 166.22 | 164.76 | 171.3 | 175.4 | 204.22 | 219.39 |
| Other Current Assets | 3.74B | 571M | 3.04B | 3.46B | 3.36B | 1.43B | 3.15B | 3.03B | 2.76B | 1.25B | 20.26B | 4.55B |
| Total Non-Current Assets | 91.92B | 85.11B | 79.09B | 78.46B | 74.83B | 72.54B | 72.26B | 71.81B | 67.89B | 73.34B | 67.04B | 77.49B |
| Property, Plant & Equipment | 12.24B | 12.35B | 11.99B | 11.83B | 11.09B | 10.87B | 11.2B | 10.62B | 10.54B | 10.92B | 10.34B | 12.28B |
| Fixed Asset Turnover | 1.10x | 1.10x | 1.21x | 1.29x | 1.24x | 1.23x | 1.21x | 1.22x | 1.13x | 1.11x | 1.07x | 0.95x |
| Goodwill | 26.82B | 25.57B | 25.55B | 25.55B | 24.96B | 24.76B | 24.93B | 25.23B | 23.06B | 23.34B | 23.42B | 29.52B |
| Intangible Assets | 40.21B | 29.41B | 29.04B | 29.24B | 27.48B | 26.91B | 27.9B | 27.77B | 26.27B | 26.88B | 26.42B | 28B |
| Long-Term Investments | 2.43B | 2.3B | 2.15B | 2.16B | 2.1B | 1.13B | 2.19B | 2.13B | 2.58B | 2.7B | 2.12B | 2.43B |
| Other Non-Current Assets | 4.98B | 10.04B | 4.78B | 4.47B | 4.11B | 4.51B | 1.39B | 1.66B | 1.21B | 1.31B | 1.11B | 1.21B |
| Total Assets | 118.53B | 115.57B | 107.29B | 104.39B | 99.94B | 102.25B | 103.52B | 97.5B | 94.33B | 103.82B | 112.7B | 110.98B |
| Asset Turnover | 0.12x | 0.12x | 0.14x | 0.15x | 0.13x | 0.13x | 0.13x | 0.13x | 0.12x | 0.11x | 0.11x | 0.11x |
| Asset Growth % | 18.6% | 13.03% | 3.64% | 7.07% | 5.94% | -1.52% | -8.14% | -12.14% | -15.95% | -14.73% | -4.87% | -9.71% |
| Total Current Liabilities | 31.37B | 27.28B | 32B | 31.71B | 31.62B | 28.69B | 28.13B | 27.61B | 29.29B | 26.39B | 48.39B | 31.91B |
| Accounts Payable | 4.32B | 4.46B | 4.55B | 4.51B | 4.26B | 4.57B | 4.09B | 4.15B | 4.06B | 4.93B | 3.87B | 5.35B |
| Days Payables Outstanding | 114.2 | 118.31 | 116.49 | 120.08 | 123.17 | 119.83 | 117.11 | 117.7 | 132.09 | 133.89 | 136.07 | 146.71 |
| Short-Term Debt | 7.62B | 5.52B | 7.52B | 8.31B | 7.8B | 8.09B | 6.57B | 7.53B | 8.34B | 6.31B | 5.67B | 8.54B |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 127M | 0 | 0 | 0 | 98M | 0 | 0 |
| Other Current Liabilities | 17.36B | 11.98B | 16.32B | 15.81B | 16.75B | 10.38B | 15.07B | 13.78B | 15.01B | 10.83B | 36.73B | 15.37B |
| Current Ratio | 0.85x | 1.12x | 0.88x | 0.82x | 0.79x | 1.04x | 1.11x | 0.93x | 0.90x | 1.16x | 0.94x | 1.05x |
| Quick Ratio | 0.65x | 0.89x | 0.68x | 0.62x | 0.61x | 0.84x | 0.90x | 0.72x | 0.71x | 0.93x | 0.83x | 0.79x |
| Cash Conversion Cycle | 117.47 | 117.76 | 104.69 | 101.04 | 93.87 | 97.07 | 107.19 | 106.2 | 100.68 | 100.97 | 131.46 | 145.22 |
| Total Non-Current Liabilities | 48.23B | 41.74B | 30.54B | 30.63B | 29.87B | 29.43B | 31.95B | 27.99B | 25.29B | 30.68B | 26.06B | 27.14B |
| Long-Term Debt | 37.45B | 29.59B | 22.6B | 22.47B | 21.67B | 21.37B | 23.75B | 19.66B | 17.19B | 18.44B | 18.07B | 18.26B |
| Capital Lease Obligations | 1.66B | 1.66B | 1.64B | 1.59B | 1.56B | 1.57B | 1.6B | 1.56B | 1.53B | 1.6B | 1.45B | 1.54B |
| Deferred Tax Liabilities | 5.1B | 8.02B | 2.17B | 2.32B | 2.55B | 2.42B | 2.22B | 2.46B | 2.31B | 6.13B | 2.46B | 2.53B |
| Other Non-Current Liabilities | 4.02B | 2.48B | 4.13B | 4.24B | 4.09B | 4.08B | 4.39B | 4.31B | 4.26B | 4.52B | 4.08B | 4.81B |
| Total Liabilities | 79.61B | 69.02B | 62.54B | 62.34B | 61.49B | 58.12B | 60.08B | 55.6B | 54.58B | 57.07B | 74.45B | 59.05B |
| Total Debt | 47B | 37.11B | 32.02B | 32.64B | 31.27B | 31.26B | 32.16B | 28.99B | 27.28B | 26.35B | 25.19B | 28.34B |
| Net Debt | 40.12B | 25.68B | 22.47B | 25.98B | 24.2B | 19.8B | 18.55B | 21.08B | 17.82B | 12.95B | 12.78B | 17.45B |
| Debt / Equity | 1.21x | 0.80x | 0.72x | 0.78x | 0.81x | 0.71x | 0.74x | 0.69x | 0.69x | 0.56x | 0.66x | 0.55x |
| Debt / EBITDA | 8.60x | 7.32x | 5.46x | 5.33x | 5.38x | 6.06x | 5.75x | 5.60x | 5.82x | 6.32x | 5.17x | 6.28x |
| Net Debt / EBITDA | 7.34x | 5.06x | 3.83x | 4.25x | 4.16x | 3.84x | 3.32x | 4.07x | 3.80x | 3.11x | 2.62x | 3.87x |
| Interest Coverage | 12.19x | 11.58x | 15.93x | 16.41x | 17.31x | 13.04x | 13.67x | 16.64x | 15.25x | 10.86x | 7.99x | 13.39x |
| Total Equity | 38.93B | 46.55B | 44.75B | 42.05B | 38.45B | 44.13B | 43.44B | 41.9B | 39.76B | 46.75B | 38.24B | 51.93B |
| Equity Growth % | 1.24% | 5.49% | 3.02% | 0.36% | -3.28% | -5.61% | 13.59% | -19.31% | -23.75% | -21.33% | -37.2% | -17.58% |
| Book Value per Share | 20.32 | 24.13 | 23.07 | 21.46 | 19.43 | 22.02 | 21.43 | 20.48 | 19.34 | 22.64 | 18.43 | 24.79 |
| Total Shareholders' Equity | 38.51B | 46.13B | 44.33B | 41.98B | 38.37B | 44.05B | 43.32B | 41.73B | 39.67B | 46.67B | 38.16B | 51.85B |
| Common Stock | 736M | 766M | 766M | 766M | 766M | 793M | 793M | 793M | 793M | 825M | 825M | 842M |
| Retained Earnings | 37.25B | 44.72B | 43.51B | 41.53B | 39.84B | 0 | 46.29B | 45.84B | 43.83B | 49.65B | 42.33B | 55.68B |
| Treasury Stock | -47M | -50M | -44M | -33M | -19M | -53M | -40M | -25M | -17M | -41M | -32M | -52M |
| Accumulated OCI | 571M | 694M | 98M | -275M | -2.22B | -3.25B | -3.73B | -4.87B | -4.93B | -3.77B | -4.96B | -4.63B |
| Minority Interest | 415M | 419M | 422M | 69M | 83M | 80M | 124M | 169M | 81M | 83M | 81M | 84M |